No, this isn't a company (I honestly didn't look to see if it is used as a ticker).
GINA is the Genetic Information Nondiscrimination Act which recently passed.
Here is an interview with Francis Collins on the subject. http://content.nejm.org/cgi/content/full/358/25/2661/DC1
Now I agree with GINA in general, and do feel it should be law. But...lets play devil's advocate because it isn't that obvious that it should be. A key provision is that insurer's and employers can't use genetic information against you. Its only marginally useful now, so we are really talking about future info and correlations. Well, why not? Can't you use it against them and thus bias the playing field?
Put employers aside for a moment and look at insurers. Insurance is based on measuring outcomes by using all the information available to asses risk. Genetic information is part of that information. Now it sounds insidious that an insurance company would deny a policy based on a genetic screen. But what prevents a customer from using that information? Insurance is based on risk analysis and the presumption that the customer is at a disadvantage in the appreciation of that risk. If that balance were to change however, wouldn't that change the entire industry? [more]
We all know the rhyme. It is what little girls are made of. Boys meanwhile get stuck with the nasties - snakes, snails, puppy dog tails. [more]
Some brief comments on my previous blog entry mentioned Covance (CVD). This is a pharmaceutical CRO (contract research organization) with a broad range of preclinical and clinical services. Most CROs are small (private) specialty companies that offer a specific service, but there are a few like Covance that are both public and have a broader spectrum of offerings, often including clinical trial management. TMO, VTIV, CRL, MDZ and others for example. [more]
I am so behind on the blog - oh well. [more]